Cesca Therapeutics Inc. Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 31, 2015, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 31, 2015, between Cesca Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

EMPLOYMENT AGREEMENT for Matthew T. Plavan
Employment Agreement • May 5th, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture • California
THERMOGENESIS CORP. and SERIES B CONVERTIBLE PREFERRED STOCK and COMMON STOCK PURCHASE WARRANTS
Subscription Agreement • January 5th, 2000 • Thermogenesis Corp • Laboratory apparatus & furniture • California
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 14th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of [ ], 2018, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 27th, 2020 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 25, 2020, between ThermoGenesis Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

LICENSE AGREEMENT
License Agreement • April 14th, 1997 • Thermogenesis Corp • Laboratory apparatus & furniture • New York
EMPLOYMENT AGREEMENT for Philip H. Coelho
Employment Agreement • September 27th, 1999 • Thermogenesis Corp • Laboratory apparatus & furniture • California
SECURITY AGREEMENT
Security Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York

This SECURITY AGREEMENT, dated as of August 31, 2015 (this “Agreement”), is among Cesca Therapeutics Inc., a Delaware corporation (the “Company” and, collectively with any Subsidiary of the Company that executes this Agreement including, including, without limitation, by delivery of an Additional Debtor Joinder in substantially the form of Annex A attached hereto, the “Debtors”) and the holders of the Company’s Senior Secured Convertible Debentures due thirty (30) years following their issuance, in the original aggregate principal amount of up to $15,000,000 (collectively, the “Debentures”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).

W I T N E S S E T H:
Registration Rights Agreement • January 5th, 2000 • Thermogenesis Corp • Laboratory apparatus & furniture • California
STRICTLY CONFIDENTIAL ThermoGenesis Holdings, Inc.
Letter Agreement • March 27th, 2020 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • New York
AT THE MARKET OFFERING AGREEMENT
Market Offering Agreement • December 13th, 2019 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • New York

ThermoGenesis Holdings, Inc. f/k/a Cesca Therapeutics Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:

2,225,000 Units THERMOGENESIS CORP. PLACEMENT AGENT AGREEMENT
Placement Agent Agreement • March 9th, 2011 • Thermogenesis Corp • Laboratory apparatus & furniture • New York
Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT
Equity Underwriting Agreement • January 31st, 2006 • Thermogenesis Corp • Laboratory apparatus & furniture • New York

ThermoGenesis Corp., a Delaware corporation (the “Company”) proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of 8,000,000 shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”) all of which will be sold by the Company. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to 800,000 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below.

PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • December 1st, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York

This letter (this “Agreement”) constitutes the agreement between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and Dawson James Securities, Inc. (“Dawson” or the “Placement Agent”) pursuant to which Dawson shall serve as the exclusive placement agent (the “Services”) for the Company, on a reasonable “best efforts” basis, in connection with the proposed offer and placement (the “Offering”) by the Company of its Securities (as defined Section 3 of this Agreement). The Company expressly acknowledges and agrees that Dawson’s obligations hereunder are on a reasonable “best efforts” basis only and that the execution of this Agreement does not constitute a commitment by Dawson to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of Dawson in placing the Securities.

RECITALS
International Distribution Agreement • October 18th, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture
Robin C. Stracey
Cesca Therapeutics Inc. • August 4th, 2016 • Laboratory apparatus & furniture • New York

This letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (“Maxim” or the “Placement Agent”) and Cesca Therapeutics Inc., a Delaware corporation (the “Company”), that Maxim shall serve as the placement agent for the Company, on a best efforts basis, in connection with the proposed placement (the “Placement”) of an aggregate of 600,000 shares of (the “Securities”) of the Company’s common stock, par value $0.001 per share (“Common Stock”). The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that Maxim would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement, including but not limited to the Purchase Agreem

STRICTLY CONFIDENTIAL Cesca Therapeutics Inc.
Letter Agreement • March 28th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
RECITALS
Oem Supply Agreement • November 10th, 2005 • Thermogenesis Corp • Laboratory apparatus & furniture • California
CESCA THERAPEUTICS INC. EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • November 15th, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California

This Executive Employment Agreement (“Agreement”) is made and entered into as of November 13, 2017, by and between CESCA THERAPEUTICS INC., a Delaware corporation (“Employer”), and XIAOCHUN (CHRIS) XU (“Executive”).

INDEMNIFICATION AGREEMENT
Indemnification Agreement • November 17th, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • Delaware

This Indemnification Agreement (this “Agreement”) is made and entered as of [DATE] by and between Cesca Therapeutics Inc., a Delaware corporation with principal place of business at 2711 Citrus Rd., Rancho Cordova, California 95742 (the “Company”), and [NAME] (“Indemnitee”) and the parties agree as follows:

CARTXPRESS BIO, INC. INVESTORS’ RIGHTS AGREEMENT
Investors’ Rights Agreement • January 4th, 2019 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • Delaware

THIS INVESTORS’ RIGHTS AGREEMENT is made as of the 1st day of January 2019, by and among CARTXpress Bio, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”

CESCA THERAPEUTICS INC. UNDERWRITING AGREEMENT
Underwriting Agreement • June 13th, 2014 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York

The undersigned, Cesca Therapeutics Inc., a Delaware corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Cesca Therapeutics Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for whom Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

THERMOGENESIS CORP. EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • July 16th, 2013 • Thermogenesis Corp • Laboratory apparatus & furniture • California

This Executive Employment Agreement (this “Agreement”) is made and entered into as of July 15, 2013 by and between Thermogenesis Corp. (“Employer”) and Kenneth L. Harris (“Executive”). For purposes of this Agreement, the term “Effective Date” shall have the same meaning as the term “Closing Date” under the Merger Agreement (as defined below). Until the Effective Date, (A) Executive shall not (i) be an employee of Employer, (ii) accrue any compensation or benefits hereunder, (iii) owe any obligations to Employer as an employee to Employer or (iv) act on behalf of or represent that he is an employee of Employer and (B) Employer shall have no obligations or duties to perform hereunder. If the Closing Date does not occur on or before December 15, 2013, this Agreement shall terminate in its entirety and neither party shall have any obligations to the other party pursuant to this Agreement. Employer and Executive agree, effective as of the Effective Date, as follows:

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 28th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 26, 2018, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AMENDMENT NO. 1 TO REVOLVING CREDIT AGREEMENT
Revolving Credit Agreement • September 22nd, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California

This Amendment No. 1 to Revolving Credit Agreement (this “Amendment No. 1”) is made effective as of September 13, 2017 (the “Effective Date”), by and between CESCA THERAPEUTICS INC., a Delaware corporation (the “Borrower”), and BOYALIFE INVESTMENT FUND II, INC., an Illinois corporation (“Lender”). Capitalized terms not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement (as defined below).

Designates portions of this document that have been omitted pursuant to a request for confidential treatment filed separately with the Commission.
Product Purchase and International Distributor Agreement • October 24th, 2012 • Thermogenesis Corp • Laboratory apparatus & furniture • California

THIS PRODUCT PURCHASE AND INTERNATIONAL DISTRIBUTOR AGREEMENT is made and entered into as of August 20, 2012 (this “Agreement”), between THERMOGENESIS CORP., a Delaware corporation, with its principal office at 2711 Citrus Road, Rancho Cordova, CA 95742, USA (“THERMO”), and GOLDEN MEDITECH HOLDINGS LIMITED, a company organized under the laws of the Cayman Islands, with its principal office at 48th Floor, Bank of China Tower, 1 Garden Road, Central, Hong Kong, S.A.R. (“GMH”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 29th, 2019 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York

This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated of July 23, 2019 and is by and among Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and the purchaser(s) identified on the signature pages hereto (each a “Buyer” and collectively, the “Buyers”).